Burden of disease from second-hand tobacco smoke exposure at home among adults from European Union countries in 2017: an analysis using a review of recent meta-analyses.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
04 2021
Historique:
received: 10 06 2020
revised: 30 11 2020
accepted: 29 12 2020
pubmed: 4 1 2021
medline: 29 6 2021
entrez: 3 1 2021
Statut: ppublish

Résumé

Smoke-free legislation reduced second-hand smoke (SHS) exposure in public places, and indirectly promoted private smoke-free settings. Nevertheless, a large proportion of adults is still exposed to SHS at home. The aim of this paper is to quantify the burden of disease due to home SHS exposure among adults in the 28-European Union (EU) countries for year 2017. The burdens by gender from lung cancer, chronic obstructive pulmonary disease (COPD), breast cancer, ischemic heart disease (IHD), stroke, asthma, and diabetes were estimated in an original research analysis using the comparative risk assessment method. Relative risks of death/diseases by gender for adults exposed to SHS at home compared to not exposed ones were estimated updating existing meta-analyses. Prevalence of home SHS exposure by gender was estimated using a multiple imputation procedure based on Eurobarometer surveys. Data on mortality and disability adjusted life years (DALYs) were obtained from the Global Burden of Disease, Injuries and Risk Factors Study. In 2017, 526,000 DALYs (0.36% of total DALYs) and 24,000 deaths (0.46% of total deaths) were attributable to home SHS exposure in the 28-EU countries, mainly from COPD and IHD. South-Eastern EU countries showed the highest burden, with proportion of DALYs/deaths attributable to SHS exposure on total higher than 0.50%/0.70%, whereas northern EU-countries showed the lowest burden, with proportions of DALYs/deaths lower than 0.25%/0.34%. The burden from SHS exposure is still significant in EU countries. More could be done to raise awareness of the health risks associated with SHS exposure at home.

Identifiants

pubmed: 33388324
pii: S0091-7435(20)30443-6
doi: 10.1016/j.ypmed.2020.106412
pii:
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106412

Investigateurs

Esteve Fernández (E)
Yolanda Castellano (Y)
Marcela Fu (M)
Montse Ballbè (M)
Beladenta Amalia (B)
Olena Tigova (O)
Maria Josè López (MJ)
Xavier Continente (X)
Teresa Arechavala (T)
Elisabet Henderson (E)
Silvano Gallus (S)
Alessandra Lugo (A)
Xiaoqiu Liu (X)
Elisa Borroni (E)
Paolo Colombo (P)
Sean Semple (S)
Rachel O'Donnell (R)
Ruaraidh Dobson (R)
Luke Clancy (L)
Sheila Keogan (S)
Hannah Byrne (H)
Panagiotis Behrakis (P)
Anna Tzortzi (A)
Constantine Vardavas (C)
Vergina Konstantina Vyzikidou (VK)
Gerasimos Bakelas (G)
George Mattiampa (G)
Roberto Boffi (R)
Ario Ruprecht (A)
Cinzia De Marco (C)
Alessandro Borgini (A)
Chiara Veronese (C)
Martina Bertoldi (M)
Andrea Tittarelli (A)
Giuseppe Gorini (G)
Giulia Carreras (G)
Barbara Cortini (B)
Simona Verdi (S)
Alessio Lachi (A)
Elisabetta Chellini (E)
Ángel López Nicolás (ÁL)
Marta Trapero-Bertran (M)
Daniel Celdrán Guerrero (DC)
Cornel Radu-Loghin (C)
Dominick Nguyen (D)
Polina Starchenko (P)
Joan B Soriano (JB)
Julio Ancochea (J)
Tamara Alonso (T)
María Teresa Pastor (MT)
Marta Erro (M)
Ana Roca (A)
Patricia Pérez (P)
Elena García Castillo (EG)

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Giulia Carreras (G)

Oncologic network, prevention and research institute (ISPRO), Florence, Italy. Electronic address: g.carreras@ispro.toscana.it.

Alessio Lachi (A)

Oncologic network, prevention and research institute (ISPRO), Florence, Italy.

Barbara Cortini (B)

Oncologic network, prevention and research institute (ISPRO), Florence, Italy.

Silvano Gallus (S)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Milan, Italy.

Maria José López (MJ)

Public Health Agency of Barcelona (ASPB), Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain; IIB Sant Pau, Barcelona, Spain.

Ángel López-Nicolás (Á)

Polytechnic University of Cartagena (UPCT), Cartagena, Spain.

Joan B Soriano (JB)

Hospital Universitario La Princesa (IISP), Madrid, Spain; Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain.

Esteve Fernandez (E)

Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias, CIBERES), Madrid, Spain; Catalan Institute of Oncology (ICO), L'Hopitalet de Llobregat, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hopitalet de Llobregat, Spain; University of Barcelona, Barcelona, Spain.

Olena Tigova (O)

Catalan Institute of Oncology (ICO), L'Hopitalet de Llobregat, Spain; Bellvitge Biomedical Research Institute (IDIBELL), L'Hopitalet de Llobregat, Spain.

Giuseppe Gorini (G)

Oncologic network, prevention and research institute (ISPRO), Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH